Addex Therapeutics (ADXN) Net Shares Issued and Repurchased (2020 - 2022)
Addex Therapeutics (ADXN) posted Net Shares Issued and Repurchased of -$5217.4 for Q2 2022, up 43.71% sequentially from -$9268.8 in Q1 2022, and down 116.79% YoY from $31081.2 in Q2 2021.
Addex Therapeutics (ADXN) Net Shares Issued and Repurchased (2020 - 2022) Analysis & Trends
Addex Therapeutics has reported Net Shares Issued and Repurchased for 3 years, with the latest figure at -$5217.4 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -5,217.42 |
| Jun 30, 2022 | -5,217.42 |
| Mar 31, 2022 | -9,268.84 |
| Mar 31, 2022 | -9,268.84 |
| Sep 30, 2021 | 443.28 |
| Sep 30, 2021 | 443.28 |
| Jun 30, 2021 | 31,081.17 |
| Jun 30, 2021 | 31,081.17 |
| Mar 31, 2021 | 28,732.10 |
| Mar 31, 2021 | 28,732.10 |
| Sep 30, 2020 | 13,171.10 |
| Sep 30, 2020 | 13,171.10 |
| Jun 30, 2020 | -38,553.67 |
| Jun 30, 2020 | -38,553.67 |
| Mar 31, 2020 | -2,684.90 |
| Mar 31, 2020 | -2,684.90 |